×
About 9,493 results

ALLMedicine™ Ankylosing Spondylitis Center

Research & Reviews  2,597 results

Vitamin D and risk of ankylosing spondylitis: A two-sample mendelian randomization study.
https://doi.org/10.1016/j.humimm.2021.09.003
Human Immunology; Jiang J, Shao M et. al.

Sep 16th, 2021 - To study whether Vitamin D levels are causally associated with ankylosing spondylitis (AS). Two-sample Mendelian randomization (TSMR) analysis was performed by employing MR-Egger regression, weighted median (WM1), inverse-variance weighted (IVW), ...

Dysregulation of ribosome-related genes in ankylosing spondylitis: a systems biology ap...
https://doi.org/10.1186/s12891-021-04662-2 10.1038/s41413-019-0057-8 10.22631/rr.2017.69997.1032 10.1002/art.1780401015 10.1136/ard.2010.140574 10.1038/gene.2017.11 10.1097/BOR.0000000000000471 10.1186/s13059-016-1104-z 10.1038/s41389-018-0044-8 10.1111/liv.12155 10.1186/1741-7015-11-98 10.1186/s12885-018-4178-z 10.1186/ar3309 10.1093/nar/gkv007 10.1002/jcb.26546 10.1073/pnas.0506580102 10.1093/bioinformatics/btu170 10.1038/nmeth.3317 10.1038/nmeth.4197 10.1186/s13059-014-0550-8 10.1002/art.1780270401 10.3390/cells8010055 10.1093/jmcb/mjv014 10.1242/dmm.020529 10.1016/j.febslet.2014.03.024 10.1038/nrc1015 10.1016/j.bbrc.2014.06.036 10.1016/j.redox.2018.08.016 10.1016/j.yexcr.2004.02.009 10.1038/onc.2017.86 10.18632/oncotarget.19383 10.1016/0165-2478(89)90152-1 10.1111/j.1365-2567.2010.03258.x 10.1002/art.39464 10.4238/2015.May.18.6 10.1007/s00296-014-3178-9 10.1161/CIRCULATIONAHA.112.125971 10.1111/bjh.15701 10.1126/science.1259077 10.1038/nri3772 10.1016/S0171-2985(11)80413-4 10.1093/gbe/evw257 10.1093/nar/25.9.1788 10.1186/1471-2148-10-70 10.1016/j.ajhg.2009.04.017 10.1016/j.bbadis.2015.02.007 10.1016/B978-0-12-802208-5.00012-6 10.1261/rna.2658311 10.7554/eLife.00762 10.1038/s41590-017-0005-y 10.1186/s13148-019-0632-2 10.1186/s13075-019-1922-y 10.7554/eLife.49551 10.1046/j.1432-0436.2003.7106002.x 10.1002/jor.20706 10.3892/ol.2017.6368 10.1007/s11926-012-0270-6 10.1186/s13075-016-1052-8 10.1097/MAJ.0b013e3182514059
BMC Musculoskeletal Disorders; Lari A, Pourbadie HG et. al.

Sep 16th, 2021 - Ankylosing spondylitis (AS) is an autoimmune rheumatic disease. Few candidate gene associations have been reported for AS and the current understanding of its pathogenesis remains still poor. Thus, the exact mechanism of AS is needed to urgently b...

Effect of bisphosphonates on ankylosing spondylitis: A meta-analysis.
https://doi.org/10.1016/j.jocn.2021.08.016
Journal of Clinical Neuroscience : Official Journal of Th... Eun IS, Park SH et. al.

Sep 13th, 2021 - This study aimed to compare outcomes between ankylosing spondylitis (AS) treated with and without bisphosphonate (BP; non-BP) through a meta-analysis. The Medline (via PubMed), Cochrane, Scopus, and Embase databases were searched for studies that ...

TNF-α-mediated m6A modification of ELMO1 triggers directional migration of mesenchymal ...
https://doi.org/10.1038/s41467-021-25710-4 10.1002/art.41042 10.1038/nrrheum.2017.188 10.1016/j.stem.2008.03.002 10.1016/j.stem.2013.09.006 10.1016/j.stem.2014.06.008 10.1038/s41467-019-11100-4 10.1002/art.39433 10.1172/JCI125212 10.1007/s00109-016-1489-x 10.1016/S0092-8674(01)00520-7 10.1038/nature09356 10.1007/s00018-019-03167-5 10.1158/0008-5472.CAN-07-0473 10.1073/pnas.1600511113 10.1038/s41590-018-0293-x 10.1093/ecco-jcc/jjy133 10.1016/j.cell.2014.08.005 10.1126/science.aau1646 10.1038/s41580-019-0168-5 10.1038/s41467-018-06898-4 10.1186/s12943-020-01249-8 10.1161/CIRCULATIONAHA.118.036146 10.1038/s12276-020-0407-z 10.1016/j.stem.2017.11.016 10.1186/s13075-019-1894-y 10.1002/art.40142 10.1038/nrdp.2015.13 10.1111/jcmm.13131 10.1038/cddis.2017.129 10.1155/2014/169082 10.1038/nrrheum.2017.22 10.1016/j.cub.2012.03.027 10.1038/ncomms2680 10.1038/s41467-020-17271-9 10.3892/mmr.2016.5398 10.1002/wrna.1 10.3389/fimmu.2019.01525 10.1007/s11427-019-9826-7 10.1186/s13046-019-1223-y 10.1016/j.molimm.2017.11.009 10.1101/gad.262766.115 10.1038/s41422-018-0040-8 10.1186/s13075-019-2014-8 10.1002/art.22290 10.1002/art.34442 10.1136/annrheumdis-2017-211544 10.1136/annrheumdis-2013-203643 10.1016/j.celrep.2018.05.089 10.4049/jimmunol.1400885 10.1002/art.1780270401 10.1016/S0076-6879(08)02617-7 10.1093/nar/gkx895 10.1002/art.34423
Nature Communications; Xie Z, Yu W et. al.

Sep 12th, 2021 - Ankylosing spondylitis (AS) is a type of rheumatic disease characterized by chronic inflammation and pathological osteogenesis in the entheses. Previously, we demonstrated that enhanced osteogenic differentiation of MSC from AS patients (AS-MSC) r...

Predominant frequency of HLA-B*27 in patients with ankylosing spondylitis in southeaste...
https://doi.org/10.1002/iid3.524
Immunity, Inflammation and Disease; Lu J, Yang J et. al.

Sep 10th, 2021 - This study was to investigate the polymorphism and distribution of alleles of HLA-B*27 in patients with ankylosing spondylitis (AS) in Han population of southeastern China. A total of 89 peripheral blood samples from southeastern Chinese Han patie...

see more →

Guidelines  11 results

2019 Update of the American College of Rheumatology/Spondylitis Association of America/...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764882
Arthritis & Rheumatology (Hoboken, N.J.); Ward MM, Deodhar A et. al.

Aug 23rd, 2019 - To update evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). We conducted updated systematic literature reviews for 20 clinical questions on pharmacologi...

Responsible, Safe, and Effective Use of Antithrombotics and Anticoagulants in Patients ...
https://www.ncbi.nlm.nih.gov/pubmed/30717501
Pain Physician; Kaye AD, Manchikanti L et. al.

Feb 6th, 2019 - Interventional pain management involves diagnosis and treatment of chronic pain. This specialty utilizes minimally invasive procedures to target therapeutics to the central nervous system and the spinal column. A subset of patients encountered in ...

The effectiveness, safety, and economic evaluation of Korean medicine for unexplained i...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779787
Medicine

Mar 6th, 2018 - Therapeutic targets have been defined for axial and peripheral spondyloarthritis (SpA) in 2012, but the evidence for these recommendations was only of indirect nature. These recommendations were re-evaluated in light of new insights. Based on the ...

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.
https://doi.org/10.1136/annrheumdis-2016-210770
Annals of the Rheumatic Diseases; van der Heijde D, Ramiro S et. al.

Jan 15th, 2017 - To update and integrate the recommendations for ankylosing spondylitis and the recommendations for the use of tumour necrosis factor inhibitors (TNFi) in axial spondyloarthritis (axSpA) into one set applicable to the full spectrum of patients with...

EULAR recommendations for cardiovascular disease risk management in patients with rheum...
https://doi.org/10.1136/annrheumdis-2016-209775
Annals of the Rheumatic Diseases; Agca R, Heslinga SC et. al.

Oct 5th, 2016 - Patients with rheumatoid arthritis (RA) and other inflammatory joint disorders (IJD) have increased cardiovascular disease (CVD) risk compared with the general population. In 2009, the European League Against Rheumatism (EULAR) taskforce recommend...

see more →

Drugs  740 results see all →

News  447 results

Fast Five Quiz: Ankylosing Spondylitis Management
https://reference.medscape.com/viewarticle/932595

May 27th, 2021 - Ankylosing spondylitis (AS) is a recurrent, progressive autoimmune disease that is associated with a high rate of disability. AS is characterized by inflammatory back pain, radiographic sacroiliitis, excess spinal bone formation, and a high preval...

Fast Five Quiz: Ankylosing Spondylitis Management
https://www.medscape.com/viewarticle/932595

May 27th, 2021 - Ankylosing spondylitis (AS) is a recurrent, progressive autoimmune disease that is associated with a high rate of disability. AS is characterized by inflammatory back pain, radiographic sacroiliitis, excess spinal bone formation, and a high preval...

Brodalumab Shows Promise in Axial Spondyloarthritis
https://www.medscape.com/viewarticle/950264

May 3rd, 2021 - NEW YORK (Reuters Health) - Brodalumab may be a potential therapeutic option for patients with axial spondyloarthritis (axSpA), according to interim results of a phase-3 study. Brodalumab, which selectively inhibits interleukin-17 receptor A (IL-1...

Major Advance in the Treatment of Axial Spondyloarthritis Coming
https://www.medscape.com/viewarticle/946520

Feb 26th, 2021 - Rheumatologists can look forward to the likely regulatory approval of the oral Janus kinase inhibitors tofacitinib and upadacitinib for the treatment of axial spondyloarthritis in the first half of 2021, speakers predicted at the 2021 Rheumatology...

Etanercept May Not Help Some With Suspected Nonradiographic Axial Spondyloarthritis
https://www.medscape.com/viewarticle/942849

Dec 17th, 2020 - Treatment with etanercept does not appear to achieve significant clinical improvement in patients suspected of having nonradiographic axial spondyloarthritis (nr-axSpA) but without positive MRI signs of sacroiliitis and/or elevated C-reactive prot...

see more →

Patient Education  2 results see all →